STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB)

CUSIP: 34385P108

Q1 2018 13F Holders as of 31 Mar 2018

Holder snapshot 7 signals
Share change
+313,998
Put/Call ratio
86%
SEC-reported price per share
$5.84
Number of holders
80
Value change
+$1,844,056
Number of buys
48
Open additional details 1 more signal available
Number of sells
25
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
391,007,800

Security key

34385P108

Report period

Q1 2018

Institutions

80

Top holders

10

Ownership snapshot

Top reported holders of LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
LEVIN CAPITAL STRATEGIES,...
Disclosed value leader
LEVIN CAPITAL STRATEGIES,...
Comparable rows
15/15
Latest evidence
31 Dec 2017
13F Lead comparable stake: 2.3% Showing 1-6 of 15 holder rows.

Quick read

LEVIN CAPITAL STRATEGIES, L.P. leads the comparable SEC ownership view at 2.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens LEVIN CAPITAL STRATEGIES, L.P.'s linked filing trail.
Comparable ownership Top 5
LEVIN CAPITAL STRATEGIES, L.P. 2.3%
PRIMECAP MANAGEMENT CO/CA/ 1.5%
Neuberger Berman Group LLC 1.2%
Russell Investments Group, Ltd. 0.98%
BlackRock Finance, Inc. 0.56%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
LEVIN CAPITAL STRATEGIES, L.P.
13F
Company
13F
2.3%
$53,994,000
9,167,070 shares
31 Dec 2017
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
1.5%
$34,016,000
5,775,143 shares
31 Dec 2017
Neuberger Berman Group LLC
13F
Company
13F
1.2%
$27,963,000
4,745,356 shares
31 Dec 2017
Russell Investments Group, Ltd.
13F
Company
13F
0.98%
$23,634,000
3,831,239 shares
31 Dec 2017
BlackRock Finance, Inc.
13F
Company
13F
0.56%
$12,870,000
2,184,882 shares
31 Dec 2017
ORBIMED ADVISORS LLC
13F
Company
13F
0.41%
$9,328,000
1,583,700 shares
31 Dec 2017
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
80
Shares
37,033,370
Rows available
80
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders
79
Q1 2018 holders
80
Holder diff
1
Investor Q4 2017 Shares Q1 2018 Shares Share Diff Share Chg % Q4 2017 value Q1 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .